NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $181,000 | -60.2% | 9,078 | -35.6% | 0.04% | -62.6% |
| Q2 2019 | $455,000 | +3.6% | 14,093 | +2.9% | 0.11% | 0.0% |
| Q1 2019 | $439,000 | -24.4% | 13,699 | +0.8% | 0.11% | -30.5% |
| Q4 2018 | $581,000 | +33.6% | 13,585 | +24.7% | 0.15% | +29.4% |
| Q3 2018 | $435,000 | -36.0% | 10,895 | -3.9% | 0.12% | -35.3% |
| Q2 2018 | $680,000 | +84.3% | 11,335 | +66.4% | 0.18% | +82.2% |
| Q1 2018 | $369,000 | -14.4% | 6,813 | -62.8% | 0.10% | -24.6% |
| Q3 2017 | $431,000 | – | 18,300 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |